DR24 DataRelease

SDY673: Characterization of maternal serum gene expression and microbiome
Status: New
Description: Plasma cell-free RNA (cfRNA) encompasses a broad spectrum of RNA species that can be derived from both human cells and microbes. Because cfRNA is fragmented and of low concentration, it has been challenging to profile its transcriptome using standard RNA-seq methods. This study assessed several recent RNA-seq methods on cfRNA samples to analyze the dynamic changes of both the human transcriptome and the microbiome of plasma during pregnancy. cfRNA reflected a well-orchestrated immune modulation during pregnancy: an up-regulation of anti-inflammatory genes and an increased abundance of anti-microbial genes, while the plasma microbiome remained relatively stable during pregnancy. The bacteria Ureaplasma shows an increased prevalence and increased abundance at postpartum, which is likely to be associated with postpartum infection. This study demonstrated that cfRNA-seq can be used to detect a number of human pathogens, including high loads of human parvovirus B19 virus (B19V), known to be a potential cause of complications in pregnancy.
Program/Contract:
ProgramContract
March of Dimes March of Dimes Human Microbiome
DOI: 10.21430/M3OARGGSY0
Subjects: 50
Study PI, contact:
NameOrganizationSite
Stephen Quake March of Dimes Prematurity Research Center at Stanford University School of Medicine March of Dimes Prematurity Research Center at Stanford University School of Medicine
Publications:
Simultaneously Monitoring Immune Response and Microbial Infections During Pregnancy through Plasma cfRNA Sequencing.. Clin Chem. Sep 2017. doi: - [Pubmed: 28904056]
Resources:
MOD_Stanford_Prematurity_Center http://prematurity.stanford.edu/]
SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA400333/]
Assays:
Assay TypeNumber of Exp. Samples
Q-PCR 111
RNA sequencing 130
Sequencing 58
Clinical Assessments:None
SDY776: Causal Relationship of Maternal Height on Birth Size and Gestational Age at Birth
Status: New
Description: Mendelian randomization analysis was conducted to assess the relationship between maternal height, gestational age and fetal growth measures. This study looked at 3 cohorts of Mother-Child pairs from Danemark (dbGAP study dbGAP https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000103.v1.p1), Norway (Norwegian Mother and Child Cohort: https://www.fhi.no/en/studies/moba/) and Finland (previous study http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1001365#pgen.1001365-Sacher1) The findings suggest that the observed association between maternal height and fetal growth measurements is mainly determined by the genetics of the baby. They also provide weak evidence that the association between maternal height and gestational age is causal.
Program/Contract:
ProgramContract
March of Dimes March of Dimes Human Microbiome
DOI: 10.21430/M3AM8G2I2Q
Subjects: 0
Study PI, contact:
NameOrganizationSite
Ge Zhang Cincinnati Children's Hospital Medical Center Cincinnati Children's Hospital Medical Center
Louis Muglia Cincinnati Children's Hospital Medical Center Cincinnati Children's Hospital Medical Center
Publications:
An Evolutionary Genomic Approach to Identify Genes Involved in Human Birth Timing. PLOS Genetics April 2011. doi: 10.1371/journal.pgen.1001365 [Pubmed: 21533219]
Assessing the Causal Relationship of Maternal Height on Birth Size and Gestational Age at Birth: A Mendelian Randomization Analysis.. PLoS Med. Aug 2015. doi: 10.1371/journal.pmed.1001865. eCollection 2015. [Pubmed: 26284790]
Resources:
GeneStation http://www.genestation.org/]
Norwegian Mother and Child Cohort Study https://www.fhi.no/en/studies/moba/]
Danish Cohort ? dbGAP https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000103.v1.p1]
Finnish Cohort http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1001365#pgen.1001365-Sacher1]
Assays:None
Clinical Assessments:None
SDY888: Human Immune Signature of Dengue virus infection- Gene Expression of CD4 subsets
Status: New
Description: The human Immune Signature of Dengue virus infection was studied in two endemic areas. T cell responses were compared in infected patients and uninfected individuals also from Dengue endemic areas.
Program/Contract:
ProgramContract
Human Immunology Project Consortium 2 (HIPC2) Human immune signatures of dengue virus and mycobacterium tuberculosis exposure in infection; disease and vaccination (HIPC2)
DOI: 10.21430/M3C4L4WD2Z
Subjects: 79
Study PI, contact:
NameOrganizationSite
Alessandro Sette La Jolla Institute for Allergy and Immunology La Jolla Institute for Allergy and Immunology
Publications:
Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA.. Nat Commun. Nov 2017. doi: 10.1038/s41467-017-01728-5. [Pubmed: 29133794]
Resources:
Assays:
Assay TypeNumber of Exp. Samples
RNA sequencing 74
Clinical Assessments:None
SDY997: AMP Lupus Network Project: Molecular Characterization of Lupus Nephritis and Correlation with Response to Therapy
Status: New
Description: Phase I will be devoted to the study of at least 45 subjects with lupus nephritis and 25 controls with the intent of achieving the following goals: (i) to assess feasibility of obtaining a sufficient yield of high quality data based on current and refined AMP SOPs, (ii) to assess recruitment rates and the number of sites necessary to effectively recruit for Phase II, (iii) to ensure that the technologies developed in Phase 0 are working well, especially with regard to transport and scaling up to handle specimens from multiple sites; (iv) to demonstrate that the selected technologies can be used for the purpose of reliably differentiating lupus nephritis kidneys from kidney tissue without lupus nephritis, (v) where necessary, to further refine the technologies before embarking on a large-scale project; and most importantly (vi) to provide critical data upon which to make rational decisions about key elements of the Phase II study design (e.g., eligibility criteria, estimates of variation for power calculations, and site-specific capability regarding patient recruitment, specimen handling, etc.).
Program/Contract:
ProgramContract
Accelerating Medicines Partnership (AMP) Accelerating Medicines Partnership (AMP)
DOI: 10.21430/M35FLWNXH1
Subjects: 105
Study PI, contact:
NameOrganizationSite
PJ Utz Stanford PEARL
Michael Holers Colorado PEARL
Publications:None
Resources:
NIH AMP RA/SLE Program https://www.niams.nih.gov/Funding/Funded_Research/AMP_RA_Lupus/default.asp]
Assays:
Assay TypeNumber of Exp. Samples
CyTOF 259
Flow Cytometry 171
RNA sequencing 13415
Clinical Assessments:
SLE Assessments
SDY998: AMP Rheumatoid Arthritis Arthroplasty Phase 1
Status: New
Description: The primary goal for RA arthroplasty P1 studies are: To establish if molecular signatures and pathways identified using core AMP technologies differ between OA and RA in 20 RA surgical samples and 10 OA arthroplasty samples.
Program/Contract:
ProgramContract
Accelerating Medicines Partnership (AMP) Accelerating Medicines Partnership (AMP)
DOI: 10.21430/M3KXJHSP4T
Subjects: 40
Study PI, contact:
NameOrganizationSite
Jennifer Anolik Rochester Rochester
Vivian Bykerk HSS HSS
Larry Moreland Pittsburg Pittsburg
Michael Holers Colorado Colorado
Peter Gregersen Northwell Northwell
Gary Firestein UCSD UCSD
PJ Utz Stanford Stanford
Michael Weisman Cedars Sinai Cedars Sinai
Publications:None
Resources:
NIH AMP RA/SLE Program https://www.niams.nih.gov/Funding/Funded_Research/AMP_RA_Lupus/default.asp]
Assays:
Assay TypeNumber of Exp. Samples
CyTOF 105
Flow Cytometry 136
Microscopy 192
RNA sequencing 3856
Clinical Assessments:
Medical History
SDY999: AMP Rheumatoid Arthritis Synovial Phase 1
Status: New
Description: The primary goal for RA synovial P1 studies are: To establish feasibility of obtaining ultrasound-guided synovial biopsies in the United States (U.S.) by comparing to frozen synovial biopsies obtained in the United Kingdom (U.K.)
Program/Contract:
ProgramContract
Accelerating Medicines Partnership (AMP) Accelerating Medicines Partnership (AMP)
DOI: 10.21430/M3XRJHRPBC
Subjects: 22
Study PI, contact:
NameOrganizationSite
Jennifer Anolik Rochester Rochester
Vivian Bykerk HSS HSS
Gary Firestein UCSD UCSD
Peter Gregersen Northwell Northwell
Michael Holers Colorado Colorado
Larry Moreland Pittsburg Pittsburg
PJ Utz Stanford Stanford
Publications:None
Resources:
Assays:
Assay TypeNumber of Exp. Samples
CyTOF 70
Flow Cytometry 173
Microscopy 229
RNA sequencing 6333
Clinical Assessments:
Medical History
SDY1109: CD4 Nicaragua Epitope ID
Status: New
Description: We performed DENV-specific epitope screening studies in the general population of Managua. Peptides with the capacity to bind HLA DR molecules most common in the Nicaraguan population have been predicted and screened in an HLA matched fashion in blood donors from the Nicaraguan Red Cross previously exposed to dengue virus.
Program/Contract:
ProgramContract
Protective Immunity Following Dengue Virus Natural Infections and Vaccination Protective Immunity Following Dengue Virus Natural Infections and Vaccination
DOI: 10.21430/M3VF5F8ANE
Subjects: 128
Study PI, contact:
NameOrganizationSite
Alessandro Sette La Jolla Institute for Allergy and Immunology La Jolla Institute for Allergy and Immunology
Publications:None
Resources:
Assays:
Assay TypeNumber of Exp. Samples
ELISPOT 1931
HLA Typing 127
Clinical Assessments:None
SDY1173: Genetic Associations with Gestational Duration and Spontaneous Preterm Birth
Status: New
Description: A genome wide association study was performed in a discovery set of samples obtained from 43,568 women of European ancestry using gestational duration as a continuous trait and term or preterm (<37 weeks) birth as a dichotomous outcome. Samples from three Nordic data sets (involving a total of 8643 women) were used to test for replication of genomic loci that had significant genome wide association (P<5.0?10?8) or an association with suggestive significance (P<1.0?10?6) in the discovery set. Four loci were associated significantly with gestational duration, and three showed association with preterm birth with genome wide significance. An analysis of mother?infant dyads suggested that these variants act at the level of the maternal genome. Data is shared at http://www.genestation.org/analysis/gwas/Zhang_2017/discovery
Program/Contract:
ProgramContract
March of Dimes March of Dimes Human Microbiome
DOI: 10.21430/M3F345ZL81
Subjects: 0
Study PI, contact:
NameOrganizationSite
Bo Jacobsson Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden
Louis Muglia Cincinnati Children?s Hospital Medical Center Cincinnati Children?s Hospital Medical Center
Publications:
Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. New England Journal of Medecine September 2017. doi: 10.1056/NEJMoa1612665 [Pubmed: 28877031]
Resources:
23 and Me data request https://researchers.23andme.org/published-data]
GeneStation http://www.genestation.org/analysis/gwas/Zhang_2017/discovery]
Assays:None
Clinical Assessments:None
SDY1175: Human microbiome characterization through massive shotgun sequencing of circulating cell-free DNA.
Status: New
Description: Cell-free DNA-derived microbiomes of 1,351 samples from 188 patients in four longitudinally sampled cohorts were analyzed. The majority of assembled sequences from cfDNA are derived from previously unidentified organisms, for instance numerous novel anelloviruses in immunocompromised patients, which represent a doubling of identified members in that viral family. Over two thirds of the sequences are bacterial, and the majority are most similar to proteobacteria; however, many large contigs can only be classified at the phylum or superkingdom level. Numerous novel phages were also found throughout the population. Multiple independent analyses confirm the existence of these novel sequences.
Program/Contract:
ProgramContract
March of Dimes March of Dimes Human Microbiome
DOI: 10.21430/M33PSZ2FHV
Subjects: 16
Study PI, contact:
NameOrganizationSite
Stephen Quake March of Dimes Prematurity Research Center at Stanford University School of Medicine March of Dimes Prematurity Research Center at Stanford University School of Medicine
Publications:
Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA.. Proc Natl Acad Sci U S A. Sep 2017. doi: 10.1073/pnas.1707009114. Epub 2017 Aug 22. [Pubmed: 28830999]
Resources:
March of Dimes Prematurity Research Center at Stanford University http://prematurity.stanford.edu/]
SRA ? Lung transplant sequencing data https://www.ncbi.nlm.nih.gov/sra/PRJNA263522]
SRA ? Bone marrow transplant sequencing data https://www.ncbi.nlm.nih.gov/sra/PRJNA385009]
SRA ? Heart transplant sequencing data https://www.ncbi.nlm.nih.gov/sra/PRJNA222186]
SRA - Pregnancy sequencing data https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA385180]
Assays:
Assay TypeNumber of Exp. Samples
Sequencing 58
Clinical Assessments:None
SDY1176: Extensive homeostatic T cell phenotypic variation within the Collaborative Cross
Status: New
Description: The Collaborative Cross (CC) is a panel of reproducible recombinant inbred mouse strains with high levels of standing genetic variation, thereby affording unprecedented opportunity to perform experiments in a small animal model containing controlled genetic diversity while allowing for genetic replicates. Here, we advance the utility of this unique mouse resource for immunology research, as it allows for both examination and genetic dissection of mechanisms behind adaptive immune states in mice with distinct and defined genetic makeups. This approach is founded on quantitative trait locus mapping: identifying genetically variant genome regions associated with phenotypic variance in traits-of-interest. Furthermore, the CC can be utilized for mouse model development; distinct strains have unique immunophenotypes and immune properties, making them suitable for research on particular diseases and infections. Here, we describe variation in cellular immune phenotypes across F1 crosses of CC strains, and reveal novel quantitative trait loci responsible for several immune phenotypes.
Program/Contract:
ProgramContract
Systems Approach to Immunity and Inflammation Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross
DOI: 10.21430/M3RKBKOYKS
Subjects: 476
Study PI, contact:
NameOrganizationSite
Jennifer Lund Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division
Publications:None
Resources:
https://research.fhcrc.org/lund/en.html Dr. Jennifer Lund's Lab]
Assays:
Assay TypeNumber of Exp. Samples
Flow Cytometry 822
Clinical Assessments:None
SDY1182: 35th Multicenter Airway Research Collaboration (MARC-35)
Status: New
Description: For enrolled infants hospitalized for bronchiolitis, structured interviews of the parents/guardians were performed by site investigators and clinical details were collected via emergency department and hospital inpatient chart reviews. Site teams collected both NS and NPA samples from infants within 24 hours of hospitalization. The composition of NS and NPA microbiota were characterized by sequencing the bacterial 16S rRNA gene V4 region on the Illumina MiSeq platform. Results indicated that there was considerable overlap between NS and NPA microbiota. Additionally, microbiota from both specimen types were associated with bronchiolitis severity.
Program/Contract:
ProgramContract
NIAID Program Prospective Cohort Study Of Severe Bronchiolitis And Risk Of Recurrent Wheezing (MARC-35 WIND)
DOI: 10.21430/M30E3B8H7H
Subjects: 0
Study PI, contact:
NameOrganizationSite
Carlos A. Camargo Massachusetts General Hospital Massachusetts General Hospital
Publications:
Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.. European Respiratory Journal November 2016. doi: 10.1183/13993003.00152-2016 [Pubmed: 27799386]
The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis.. Microbiome. Jan 2018. doi: 10.1186/s40168-017-0385-0. [Pubmed: 29298732]
Resources:
The WIND Study www.windstudy.org]
Assays:None
Clinical Assessments:None
SDY67: Bioinformatics Approach to 2010-2011 TIV Influenza A/H1N1 Vaccine Immune Profiling
Status: Updated
Description: Aim 1: Characterize Immune Profiles Over Time, Aim 2: Correlate Immune Profiles with Vaccine Immunogenicity,Aim 3: Replication of Immune Profiles and Verification of Models
Program/Contract:
ProgramContract
Human Immunology Project Consortium 1 (HIPC1) Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
DOI: 10.21430/M3OYWCJHO1
Subjects: 159
Study PI, contact:
NameOrganizationSite
Gregory Poland Mayo Clinic Mayo Clinic
Publications:
The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.. PLoS One. Mar 2015. doi: 10.1371/journal.pone.0122282. eCollection 2015. [Pubmed: 25816015]
System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination.. PLoS One. Mar 2016. doi: 10.1371/journal.pone.0152034. eCollection 2016. [Pubmed: 27031986]
Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals.. Heliyon. May 2016. doi: 10.1016/j.heliyon.2016.e00098. eCollection 2016. [Pubmed: 27441275]
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.. Elife. Nov 2017. doi: 10.7554/eLife.26476. [Pubmed: 29130882]
Resources:
NIH Reporter 5U01AI089859-05 http://projectreporter.nih.gov/project_info_details.cfm?aid=8695082]
Assays:
Assay TypeNumber of Exp. Samples
Cell Culture 556
DNA methylation profiling assay 952
ELISPOT 1113
Flow Cytometry 3387
Hemagglutination Inhibition 1272
Mass Spectrometry 61
Meso Scale Discovery ECL 1272
PCR 466
Q-PCR 159
RNA sequencing 1100
Virus Neutralization 635
Clinical Assessments:None
SDY144: Systems Biology Approach to Study Influenza Vaccine 2011-12 in Healthy Children (see companion studies SDY364, SDY368, SDY387)
Status: Updated
Description: The treatment of pediatric immune system dysfunctions depends upon the basic understanding of its molecular and cellular components, as well as the inherent relationships between these components. Specifically, such knowledge requires an appreciation of B-Iymphocytes, T lymphocytes, natural killer cells and dendritic cells. Research investigating these cells and their functions necessitates the availability and acquisition of peripheral blood samples from healthy children to form control data groups against which various experimental conditions can be measured. Volunteers will be asked to donate blood samples to be used to further study the circulating dendritic cell subpopulations and establish their normal ranges. Blood samples will also be used to isolate antigen specific T lymphocytes, serve as a monocyte source and establish gene signatures.

The assay results from SDY144's EXP13603, EXP11769, and EXP13604 are the same as for this study. The difference is how the floe cytometry results were analyzed in this study versus SDY144.
Program/Contract:
ProgramContract
Human Immunology Project Consortium 1 (HIPC1) Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
DOI: 10.21430/M3ANETOJEC
Subjects: 17
Study PI, contact:
NameOrganizationSite
Octavio Ramilo Nationwide Children's Hospital Nationwide Children's Hospital
Publications:
Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.. J Infect Dis. Jul 2014. doi: 10.1093/infdis/jiu079. Epub 2014 Feb 4. [Pubmed: 24495909]
Resources:
Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52005]
EMBL-EBI http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-52005/]
Assays:
Assay TypeNumber of Exp. Samples
DNA microarray 64
Flow Cytometry 486
Hemagglutination Inhibition 32
Virus Neutralization 96
Clinical Assessments:
Medical History
Vaccination History
Vital Signs
SDY465: Exploring the human maternal microbiome and its contribution to preterm birth
Status: Updated
Description: Preterm births occur in 12 percent of pregnancies. Preterm infants are at risk for long term health problems such as impaired hearing and vision, cerebral palsy and developmental delays. This study will characterize the human maternal microbiome and host response profiles associated with term and preterm births and identify features of each that are predicitive of preterm labor and delivery
Program/Contract:
ProgramContract
March of Dimes March of Dimes Human Microbiome
DOI: 10.21430/M3D491LGDT
Subjects: 47
Study PI, contact:
NameOrganizationSite
David Relman March of Dimes Prematurity Research Center at Stanford University School of Medicine March of Dimes Prematurity Research Center at Stanford University School of Medicine
Publications:
Temporal and spatial variation of the human microbiota during pregnancy.. Proc Natl Acad Sci U S A. Sep 2015. doi: 10.1073/pnas.1502875112. Epub 2015 Aug 17. [Pubmed: 26283357]
Resources:
March of Dimes Prematurity Research Center at Stanford University http://prematurity.stanford.edu/]
Stanford University R Markdown http://statweb.stanford.edu/~susan/papers/PNASRR.html.]
Assays:
Assay TypeNumber of Exp. Samples
16S rRNA gene sequencing 4122
Clinical Assessments:
Maternal_Health_and_Pregnancy_Status
SDY522: Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine (2011-12) Correlate With the Kinetics and Magnitude of Interferon Signaling in Children (see companion studies SDY144, SDY360)
Status: Updated
Description: The treatment of pediatric immune system dysfunctions depends upon the basic understanding of its molecular and cellular components, as well as the inherent relationships between these components. Specifically, such knowledge requires an appreciation of B-Iymphocytes, T lymphocytes, natural killer cells and dendritic cells. Research investigating these cells and their functions necessitates the availability and acquisition of peripheral blood samples from healthy children to form control data groups against which various experimental conditions can be measured. Volunteers will be asked to donate blood samples to be used to further study the circulating dendritic cell subpopulations and establish their normal ranges. Blood samples will also be used to isolate antigen specific T lymphocytes, serve as a monocyte source and establish gene signatures.
Program/Contract:
ProgramContract
Human Immunology Project Consortium 1 (HIPC1) Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
DOI: 10.21430/M3XZMA3XL4
Subjects: 20
Study PI, contact:
NameOrganizationSite
Octavio Ramilo Nationwide Children's Hospital Nationwide Children's Hospital
Publications:
Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.. J Infect Dis. Jul 2014. doi: 10.1093/infdis/jiu079. Epub 2014 Feb 4. [Pubmed: 24495909]
Resources:
Assays:
Assay TypeNumber of Exp. Samples
DNA microarray 72
Flow Cytometry 64
Hemagglutination Inhibition 36
Virus Neutralization 108
Clinical Assessments:
Medical History
Vaccination History
Vital Signs
SDY788: Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates
Status: Updated
Description: Single-cell mass cytometry by time-of-flight (CyTOF) phenotyping, gene arrays, and phosphoepitope flow cytometry were performed in 20 highly sensitized kidney transplant candidates undergoing desensitization therapy.
Program/Contract:
ProgramContract
Improving Kidney Transplant Outcomes By Using Novel B-cell Immune Profiling Improving Kidney Transplant Outcomes By Using Novel B-cell Immune Profiling
DOI: 10.21430/M3R0UUBC6K
Subjects: 22
Study PI, contact:
NameOrganizationSite
Julie Yabu Stanford University Stanford
Publications:
Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates.. PLoS One. Apr 2016. doi: 10.1371/journal.pone.0153355. eCollection 2016. [Pubmed: 27078882]
Resources:
Assays:
Assay TypeNumber of Exp. Samples
CyTOF 141
DNA microarray 39
Flow Cytometry 360
Clinical Assessments:None
Back to top